The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed. These poor outcomes are partly due to the lack of effective ...
Feb 3, 2021
0
42
In a new study led by Yale Cancer Center, researchers have discovered a novel metabolic gatekeeper mechanism for leukemia. This mechanism depends on a molecule called PON2, which could lead to a new treatment for the disease. ...
Feb 1, 2021
0
64
Errors in the way chromosomes are packed into antibody-producing B cells appear to play a role in the development of B cell-related blood cancers, according to a new study by researchers at Columbia University Vagelos College ...
Feb 1, 2021
0
42
New data suggest that nearly all COVID-19 survivors have the immune cells necessary to fight re-infection.
Jan 6, 2021
0
538
Australian researchers have revealed—for the first time—that people who have been infected with the COVID-19 virus have immune memory to protect against reinfection for at least eight months.
Dec 22, 2020
3
3081
Scientists at Scripps Research have demonstrated a promising new strategy for treating lymphomas, a group of cancers that begin in infection-fighting cells of the immune system called lymphocytes.
Dec 16, 2020
0
73
New research by scientists at the University of Chicago suggests a person's antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals ...
Dec 11, 2020
2
161
Mutations in proteins called histone H1, which help package DNA in chromosomes, are a frequent cause of lymphomas, according to a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and The Rockefeller ...
Dec 10, 2020
0
84
Unlike so many other deadly viruses, HIV still lacks a vaccine. The virus—which continues to infect millions around the world—has proven especially tricky to prevent with conventional antibodies, in part because it evolves ...
Nov 19, 2020
0
72
Immunotherapies have transformed the treatment of several types of cancer over the last decade. Yet they focus on reactivating one arm of the immune system: cytotoxic T cells, which sniff out and kill tumor cells.
Nov 19, 2020
0
59
